These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 17198662)

  • 1. [Control of coronary risk factors in secondary prevention: PRESENAP study].
    Tranche Iparraguirre S; López Rodríguez I; Mostaza Prieto JM; Soler López B; Mantilla Morató MT; Taboada Taboada M; Lahoz Rallo C; Martín-Jadraque L; Monteiro B;
    Med Clin (Barc); 2006 Nov; 127(20):765-9. PubMed ID: 17198662
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence of diabetes and other cardiovascular risk factors in an Iranian population with acute coronary syndrome.
    Esteghamati A; Abbasi M; Nakhjavani M; Yousefizadeh A; Basa AP; Afshar H
    Cardiovasc Diabetol; 2006 Jul; 5():15. PubMed ID: 16842631
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Left ventricular hypertrophy in the Spanish hypertensive population. The ERIC-HTA study].
    Lozano JV; Redón J; Cea-Calvo L; Fernández-Pérez C; Navarro J; Bonet A; González-Esteban J
    Rev Esp Cardiol; 2006 Feb; 59(2):136-42. PubMed ID: 16540035
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Prospective Cardiovascular Münster (PROCAM) study: prevalence of hyperlipidemia in persons with hypertension and/or diabetes mellitus and the relationship to coronary heart disease.
    Assmann G; Schulte H
    Am Heart J; 1988 Dec; 116(6 Pt 2):1713-24. PubMed ID: 3202078
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence of cardiovascular risk factors in men with stable coronary heart disease in France and Spain.
    Grau M; Bongard V; Fito M; Ruidavets JB; Sala J; Taraszkiewicz D; Masia R; Galinier M; Subirana I; Carrié D; Vila J; Marrugat J; Ferrières J;
    Arch Cardiovasc Dis; 2010 Feb; 103(2):80-9. PubMed ID: 20226427
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ESH-ESC guidelines for the management of hypertension.
    Erdine S; Ari O; Zanchetti A; Cifkova R; Fagard R; Kjeldsen S; Mancia G; Poulter N; Rahn KH; Rodicio JL; Ruilope LM; Staessen J; van Zwieten P; Waeber B; Williams B
    Herz; 2006 Jun; 31(4):331-8. PubMed ID: 16810473
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Variations in the Prevalence of Risk Factors for Coronary Artery Disease in Rio Grande do Sul-Brazil: A Comparative Analysis between 2002 and 2014.
    Gus I; Ribeiro RA; Kato S; Bastos J; Medina C; Zazlavsky C; Portal VL; Timmers R; Markoski MM; Gottschall CA
    Arq Bras Cardiol; 2015 Dec; 105(6):573-9. PubMed ID: 26761368
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence of atherogenic dyslipidemia in primary care patients at moderate-very high risk of cardiovascular disease. Cardiovascular risk perception.
    Plana N; Ibarretxe D; Cabré A; Ruiz E; Masana L
    Clin Investig Arterioscler; 2014; 26(6):274-84. PubMed ID: 24931442
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence of coronary heart disease and risk factors in an urban Indian population: Jaipur Heart Watch-2.
    Gupta R; Gupta VP; Sarna M; Bhatnagar S; Thanvi J; Sharma V; Singh AK; Gupta JB; Kaul V
    Indian Heart J; 2002; 54(1):59-66. PubMed ID: 11999090
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Therapeutic approach to dyslipidemia and goal achievement in a Spanish population with type 2 diabetes without cardiovascular disease].
    Pérez A; González Blanco C; Hernández-Presa MÁ; Chaves J
    Endocrinol Nutr; 2011; 58(6):283-90. PubMed ID: 21641286
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Primary care of patients with high cardiovascular risk : Blood pressure, lipid and diabetic target levels and their achievement in Hungary.
    Szigethy E; Jancsó Z; Móczár C; Ilyés I; Kovács E; Róbert Kolozsvári L; Rurik I
    Wien Klin Wochenschr; 2013 Jul; 125(13-14):371-80. PubMed ID: 23824265
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Trends in cardiovascular risk factors among people with diabetes in a population based study, Health Survey for England 1994-2009.
    Samaranayaka S; Gulliford MC
    Prim Care Diabetes; 2013 Oct; 7(3):193-8. PubMed ID: 23685024
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CUORE project: implementation of the 10-year risk score.
    Palmieri L; Rielli R; Demattè L; Donfrancesco C; Ciccarelli P; De Sanctis Caiola P; Dima F; Lo Noce C; Brignoli O; Cuffari A; Giampaoli S
    Eur J Cardiovasc Prev Rehabil; 2011 Aug; 18(4):642-9. PubMed ID: 21450625
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A British Cardiac Society survey of the potential for the secondary prevention of coronary disease: ASPIRE (Action on Secondary Prevention through Intervention to Reduce Events).
    Bowker TJ; Clayton TC; Ingham J; McLennan NR; Hobson HL; Pyke SD; Schofield B; Wood DA
    Heart; 1996 Apr; 75(4):334-42. PubMed ID: 8705756
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Blood pressure control in hypertensive Spanish population attended in primary care setting. The PRESCAP 2010 study].
    Llisterri Caro JL; Rodríguez Roca GC; Alonso Moreno FJ; Prieto Díaz MA; Banegas Banegas JR; Gonzalez-Segura Alsina D; Lou Arnal S; Divisón Garrote JA; Beato Fernández P; Barrios Alonso V;
    Med Clin (Barc); 2012 Dec; 139(15):653-61. PubMed ID: 22436384
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heartwatch: a secondary prevention programme in primary care in Ireland.
    Bennett K; Jennings S; Collins C; Boland M; Leahy J; Bedford D; Shelley E
    Eur J Cardiovasc Prev Rehabil; 2008 Dec; 15(6):651-6. PubMed ID: 19177599
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence of coronary artery disease and its risk factors in Kerala, South India: a community-based cross-sectional study.
    Krishnan MN; Zachariah G; Venugopal K; Mohanan PP; Harikrishnan S; Sanjay G; Jeyaseelan L; Thankappan KR
    BMC Cardiovasc Disord; 2016 Jan; 16():12. PubMed ID: 26769341
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence of dyslipidemia and general ineffectiveness of its treatment in both primary and secondary prevention of coronary heart disease within family medicine framework--results of LIPIDOGRAM 2005--a nationwide epidemiological study. Dyslipidemia in Poland--ineffective treatment.
    Konduracka E; Jóźwiak J; Mastej M; Lukas W; Tykarski A; Szczepaniak-Chicheł L; Piwowarska W
    Przegl Lek; 2008; 65(12):834-7. PubMed ID: 19441674
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Cardiovascular risk of hypertensive people with long-range monitoring. The effect of aging (Ciclo Risk Study)].
    García-Ortiz L; Gómez-Marcos MA; González-Elena LJ; Maderuelo-Fernández JA; Ramos-Delgado E; Torrecilla-Garcia M
    Rev Esp Salud Publica; 2007; 81(4):365-73. PubMed ID: 18041539
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS. Air Force/Texas Coronary Atherosclerosis Prevention Study.
    Downs JR; Clearfield M; Weis S; Whitney E; Shapiro DR; Beere PA; Langendorfer A; Stein EA; Kruyer W; Gotto AM
    JAMA; 1998 May; 279(20):1615-22. PubMed ID: 9613910
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.